What is Genome Korea?
Genome Korea in Ulsan Project
The Ulsan 10,000 Genome Project, entitled the Genome Korea in Ulsan has been launched in Ulsan Metropolitan City
on the 25th of Nov. 2015.
The consortium includes the Ulsan Metropolitan City, Ulsan National Institute of Science and Technology (UNIST),
Ulsan University Hospital, and the University of Ulsan.
This is a large-scale publicly-funded genome project in Korea, with the estimated funding of ~25 million USD by 2019.
The goal is to map complete genomic and other omics information diversity of Koreans, constructing standardized gene
variation database, detecting rare genetic mutations, and providing well-annotated full genome information for growing
genomic industry of Korea. The consortium will seek necessary funding from public and private sectors to achieve its goal
of sequencing all the Koreans in the next decades. The initial 10,000 samples will be collected from both healthy people
and immunocompromised people.
The projects practical aim is to develop an industrial foundation in genomics for future biomedical industry.
Ulsan, known as the capital of Korean industrialization, has a well established industrial infrastructure. The consortium
will facilitate developing new sequencing and analysis technologies to achieve personalized medicine in Korea.
This project is complementary to Korean governments on-going Multi-ministry Genomics Initiative which has
started in 2013 with a total sum of 500 million USD for 8 years to carry out human, agricultural, and medical genomics projects.
Genome Korea is in collaboration with Harvard Medical Schools Personal Genome Project (PGP), led by Professor
George Church who developed key genome sequencing and editing technologies for decades. UNIST and
Harvard Medical School will sign an MOU for the Ulsan 10,000 genome project.
Genome Korea is a participatory project where volunteers donate blood samples and personal and clinical
information. Korean PGP project, led by Prof. Jong Bhak at UNIST have already published over 50 high quality
individual genomes with the Korean reference genome assembly, funded by Korean government.
Ulsans 10,000 genome is the first large scale public project that will expand to the whole Korean population
which is similar to 100,000 UK genome and US president Obamas 1 million genome project.
Ulsan mayor, Mr. Ki-hyun Kim, emphasized the significance of Genome Korea in Ulsan project by addressing
We aim to make Ulsan as the hub of genomic industry in Asia and beyond by linking it to diagnostic and
therapeutic medical industry as a key Korean economic industrialization driving force.
UNIST president, Prof. Mooyoung Jung has an ambitious plan to make this Ulsan 10,000 genome project,
by raising the technology level to the world top level innovative research by analyzing 10,000 people genomes at UNIST.
Korea's aging population is growing at a rapid pace. We, therefore, need genome industry to lower the
medical cost and prevent national scale infectious disease endemic analyzing genomes and associated omics
information. This must be accompanied by the commercialization of the technologies and Genome project
can function as the seed of future biomedical revolution in business and society, says Prof. Jong Bhak, the
lead researcher of this project.
Ulsan is the most industrialized city in Korea which hosts global business cooperations such as Hyundai, SK,
and Samsung. Ulsans main industry has been mostly heavy industrials such as car manufacturing,
ship building, and oil refining. Currently, Ulsan plans to develop new high-tech industries such as biomedical devices,
reagents, new materials, energy storage, and information technologies. Ulsan 10K genome is a part of
such an effort to recruit skilled labor and highly value-added business entities.
UNIST is a new science and technology university in Korea established by the government in 2009.